While analyzing the frequency of the co-occurrence of genetically altered TJP1–3 in the same specimen, it was found that genetic alterations of the other TJP family members were not significant in bladder cancer patients (Supplementary Table 1). This evidence concerns the gene TJP1 and urinary bladder cancer.